Lu K, Li H, Sun L, Dong X, Fan Y, Dong D
Front Immunol. 2025; 16:1545185.
PMID: 40034711
PMC: 11872941.
DOI: 10.3389/fimmu.2025.1545185.
Patel S, Patel S, Zhang W, Singal A, Cheung R, Wong R
Gastro Hep Adv. 2025; 4(4):100609.
PMID: 40026700
PMC: 11869966.
DOI: 10.1016/j.gastha.2024.100609.
Maliha S, Guo G
Liver Res. 2025; 5(3):142-150.
PMID: 39957843
PMC: 11791795.
DOI: 10.1016/j.livres.2021.02.002.
Ali R, Li H, Zhang H, Pan W, Reeder S, Harris D
Eur Radiol. 2025; .
PMID: 39779515
DOI: 10.1007/s00330-024-11312-3.
Luthra R, Sheth A
Adv Ther. 2024; 42(2):1165-1195.
PMID: 39739194
PMC: 11787050.
DOI: 10.1007/s12325-024-03085-4.
Alcohol-associated hepatitis trends before and following the onset of the COVID-19 pandemic across two distinct cohorts in the United States and Hong Kong.
Yang Z, Hui V, Yip T, Lai M, Lai J, Wong V
JHEP Rep. 2024; 7(1):101254.
PMID: 39717504
PMC: 11664074.
DOI: 10.1016/j.jhepr.2024.101254.
LI-RADS in 2024: recent updates, planned refinements, and future directions.
Kierans A, Fowler K, Chernyak V
Abdom Radiol (NY). 2024; .
PMID: 39671010
DOI: 10.1007/s00261-024-04730-w.
Overweight Impacts Histological Disease Activity of De Novo Metabolic Dysfunction-Associated Steatotic Liver Disease After Liver Transplantation.
Campos-Murguia A, Guetzlaff L, Bosselmann E, Engel B, Hartleben B, Wedemeyer H
Clin Transplant. 2024; 38(11):e70039.
PMID: 39575514
PMC: 11582943.
DOI: 10.1111/ctr.70039.
Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022.
Park J, Yoo J, Lee D, Chang Y, Jo H, Cho Y
Korean J Intern Med. 2024; 39(6):931-944.
PMID: 39444335
PMC: 11569921.
DOI: 10.3904/kjim.2024.164.
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis.
He C, Hu Z, Lin Z, Chen H, Cao C, Chen J
BMC Cancer. 2024; 24(1):1042.
PMID: 39179959
PMC: 11342564.
DOI: 10.1186/s12885-024-12808-3.
Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.
Hvid H, Hjuler S, Bedossa P, Tiniakos D, Kamzolas I, Harder L
Am J Physiol Gastrointest Liver Physiol. 2024; 327(4):G571-G585.
PMID: 39041677
PMC: 11482250.
DOI: 10.1152/ajpgi.00120.2024.
Transplantation for alcohol-associated liver disease in the modern era: Benefits and issues unresolved.
Deutsch-Link S, Byers I, Serper M
Liver Transpl. 2024; 31(1):4-6.
PMID: 39018083
PMC: 11637893.
DOI: 10.1097/LVT.0000000000000441.
The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.
Ayyala-Somayajula D, Dodge J, Zhou K, Terrault N, Yuan L
Hepatol Commun. 2024; 8(7).
PMID: 38967588
PMC: 11227353.
DOI: 10.1097/HC9.0000000000000455.
The Impact of Donor Body Mass Index on Safety and Outcomes in Living Donor Liver Transplantation: An Analysis of the National United States Database.
Banker A, Cywes C, Munoz N, Taj R, Bittermann T, Abt P
Transplant Direct. 2024; 10(7):e1673.
PMID: 38911275
PMC: 11191960.
DOI: 10.1097/TXD.0000000000001673.
Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort study.
Fishman J, Qian C, Kim Y, Rochon H, Szabo S, Sun R
J Manag Care Spec Pharm. 2024; 30(9):929-941.
PMID: 38845444
PMC: 11365567.
DOI: 10.18553/jmcp.2024.24069.
Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients.
Flynn S, Saxena V, Brandman D
J Prim Care Community Health. 2024; 15:21501319241247974.
PMID: 38650519
PMC: 11036922.
DOI: 10.1177/21501319241247974.
Evolution of Liver Transplantation Indications: Expanding Horizons.
Battistella S, Grasso M, Catanzaro E, DArcangelo F, Corra G, Germani G
Medicina (Kaunas). 2024; 60(3).
PMID: 38541138
PMC: 10972065.
DOI: 10.3390/medicina60030412.
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype.
Samala N, Xin Y, Wilson L, Yates K, Loomba R, Hoofnagle J
Am J Gastroenterol. 2024; 119(9):1857-1865.
PMID: 38483303
PMC: 11399313.
DOI: 10.14309/ajg.0000000000002756.
Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study.
Akarsu M, Dolu S, Harputluoglu M, Yilmaz S, Akyildiz M, Gencdal G
Hepatol Forum. 2024; 5(1):3-6.
PMID: 38283275
PMC: 10809344.
DOI: 10.14744/hf.2023.2023.0010.
Effect of donor genotype on patient survival after liver transplant: a retrospective cohort study.
Kozlitina J, Cohen N, Sturtevant D, Cohen J, Murphey-Half C, Saltarrelli J
EClinicalMedicine. 2024; 67:102350.
PMID: 38169797
PMC: 10758751.
DOI: 10.1016/j.eclinm.2023.102350.
